Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights strong financial health with a 17% increase in backlog and a strong current ratio. Despite a decrease in EPS and lower margins due to program delays, the company expects margin normalization and revenue recovery. The strategic focus on quantum technology and potential in military and space applications is promising. Analysts' concerns were addressed, and the Colorado operations are anticipated to contribute positively soon. Overall, positive financial metrics, strategic growth plans, and optimistic guidance suggest a positive stock price movement.
Revenue $17.1 million for the 3 months ended October 31, 2025, compared to $15.8 million for the same period of the prior fiscal year, representing an increase of 8.2%. The increase was due to higher revenue from non-space Department of Defense products in the FEI-Zyfer segment.
Revenue from commercial and U.S. government satellite programs $4.6 million or 27% of total revenue, compared to $9.4 million or 59% in the same period of the prior fiscal year. This represents a significant decrease due to a change in the mix of high-margin production satellite programs.
Revenue from non-space U.S. government and Department of Defense customers $11.9 million or 69% of total revenue, compared to $5.8 million or 37% in the same period of the prior fiscal year, representing a significant increase due to higher shipment-based products and products accounted for under the percentage of completion method.
Other commercial and industrial revenues Approximately $560,000 compared to approximately $591,000 in the prior fiscal year, showing a slight decrease.
Gross margin and gross margin rate Both decreased compared to the same period of the prior fiscal year. The decrease was due to a change in the mix of high-margin production satellite programs versus lower-margin programs with significant nonrecurring engineering efforts.
Selling and General Administrative (SG&A) expenses Approximately 21% of consolidated revenues for both the current and prior fiscal year periods. The increase in SG&A expense was due to fluctuations in various expense accounts.
Research and Development (R&D) expenses Decreased to approximately $1.2 million (7% of consolidated revenue) from $1.6 million (10% of consolidated revenue) in the prior fiscal year, a decrease of approximately $400,000. The decrease was attributed to current operational needs supporting ongoing programs.
Operating income Approximately $1.7 million for the 3 months ending October 31, 2025, compared to approximately $2.6 million in the prior fiscal year, representing a decrease due to lower gross margin and increased SG&A expenses.
Pretax income Approximately $1.8 million for the 3 months ending October 31, 2025, compared to approximately $2.7 million for the same period of the prior fiscal year, showing a decrease.
Tax benefit/provision A tax benefit of $31,000 for the 3 months ending October 31, 2025, compared to a tax provision of $139,000 for the same period of the prior fiscal year.
Net income Approximately $1.8 million or $0.18 per share for the 3 months ending October 31, 2025, compared to approximately $2.7 million or $0.28 per share for the same period of the prior fiscal year, showing a decrease.
Fully funded backlog Approximately $82 million at the end of October 2025, compared to approximately $70 million at the end of April 2025, representing an increase of 17%.
Working capital Approximately $31 million as of October 31, 2025, with a current ratio of approximately 2.6:1, indicating a strong financial position.
Quantum sensing and ALT-PNT programs: The company is optimistic about growth in quantum sensing, proliferated satellites, and Alternative Position, Navigation, and Timing (ALT-PNT) programs. These new markets are expected to be additive to the already strong core business.
Space technology: The company’s technology is onboard the U.S. Space Force’s NTS-3 experimental navigation satellite, highlighting its strategic relevance in advancing next-generation PNT architectures.
Defense and space markets: The company is experiencing significant growth in defense and space markets, with increasing participation in modernization initiatives such as missile defense and drone procurement. The Pentagon plans to procure 200,000 drones by 2027, showcasing the scale of modernization.
Revenue growth: Revenue for the quarter was $17.1 million, up 24% sequentially, marking the third highest quarter of revenue in the past decade.
Backlog growth: The company’s backlog reached $82 million, the highest in its history, up 17% since fiscal year-end. The backlog is expected to exceed $100 million in the near future.
Profitability and margins: Gross margin and operating income decreased compared to the prior year due to a shift in program mix, but the company remains committed to improving profitability.
Strategic partnerships: The company maintains strong relationships with major prime contractors and next-generation defense companies, often serving as a sole source provider.
Expansion in new technologies: The company is focusing on quantum sensing, magnetometers, and proliferated satellites as future growth areas, building on its industry-leading capabilities.
Revenue Variability: The company experienced revenue variability due to customer-driven delays on key programs and the pulling forward of revenue from fiscal 2026 into fiscal 2025. This could lead to uneven revenue recognition in future quarters.
Gross Margin Decline: Gross margin and gross margin rate decreased compared to the prior fiscal year due to a shift in the mix of high-margin production satellite programs to lower-margin programs with significant nonrecurring engineering efforts.
R&D Expenditure Fluctuations: R&D expenses decreased by $400,000 compared to the prior fiscal year, which could impact the company's ability to maintain state-of-the-art products if not managed carefully.
Operating Income Decline: Operating income decreased from $2.6 million to $1.7 million year-over-year, driven by lower gross margins and increased SG&A expenses.
Dependence on Defense and Space Markets: The company is heavily reliant on defense and space markets, which are subject to government budget allocations and policy changes, potentially impacting future revenue streams.
Nonlinear Growth Trajectory: The company acknowledges that its growth trajectory is not linear, which could lead to periods of financial instability or investor uncertainty.
Revenue Growth: The company expects to build upon a new higher revenue baseline in the years ahead, supported by a strong multiyear growth period.
Backlog Growth: The company anticipates backlog to exceed $100 million in the near future, driven by strong existing business and new contracts.
Market Expansion: The company expects to participate meaningfully in expanding sectors such as quantum sensing, proliferated satellites, and Alternative Position, Navigation, and Timing (ALT-PNT) programs.
Defense and Space Business: The company envisions sharp growth in its defense business for many years, supported by increasing defense spending and modernization initiatives. It also sees a long runway of growth in the space business.
Future Awards: The company anticipates multiple awards in the coming months, some as large or larger than historical awards.
Technological Advancements: The company plans to continue investing in R&D to maintain state-of-the-art products and expects to play a significant role in next-generation defense and space technologies.
The selected topic was not discussed during the call.
The earnings call highlights strong financial health with a 17% increase in backlog and a strong current ratio. Despite a decrease in EPS and lower margins due to program delays, the company expects margin normalization and revenue recovery. The strategic focus on quantum technology and potential in military and space applications is promising. Analysts' concerns were addressed, and the Colorado operations are anticipated to contribute positively soon. Overall, positive financial metrics, strategic growth plans, and optimistic guidance suggest a positive stock price movement.
The earnings call reveals significant concerns: decreased revenue, lower R&D spending, and increased SG&A expenses. Despite a slight backlog increase and share repurchase plans, the company's dependence on government contracts and global timing vulnerabilities add risk. The Q&A section highlights unclear responses regarding key technologies, further dampening sentiment. Overall, the negative financial results and uncertainties outweigh the positive aspects, leading to a negative sentiment.
The earnings call indicates strong financial performance with significant increases in pre-tax and net income, driven by improved operations and tax benefits. Although backlog decreased slightly, the company's liquidity and current ratio are strong. The Q&A section reveals optimism about future contracts in quantum sensing and government projects, despite some vagueness in management's responses. Overall, the financial health and future prospects suggest a positive sentiment, likely resulting in a stock price increase of 2% to 8% over the next two weeks.
The earnings call presents strong financial performance with significant increases in net income and margins. The optimistic guidance on government funding and new business opportunities, despite a slight backlog decrease, suggests positive future prospects. The Q&A section reveals cautious optimism in quantum sensing and satellite developments, while management's responses are generally positive. These factors, coupled with a solid working capital position and positive guidance, indicate a likely stock price increase in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.